Country: United States
Language: English
Source: NLM (National Library of Medicine)
SODIUM PICOSULFATE (UNII: LR57574HN8) (DEACETYLBISACODYL - UNII:R09078E41Y), MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838), ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL)
Ferring Pharmaceuticals Inc.
SODIUM PICOSULFATE
SODIUM PICOSULFATE 10 mg in 16.1 g
ORAL
PRESCRIPTION DRUG
Prepopik® is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. Prepopik is contraindicated in the following conditions: - Patients with severe renal impairment (creatinine clearance less than 30 mL/minute) which may result in accumulation of magnesium [see Warnings and Precautions (5.4)] - Gastrointestinal obstruction or ileus [see Warnings and Precautions (5.6)] - Bowel perforation [see Warnings and Precautions (5.6)] - Toxic colitis or toxic megacolon - Gastric retention - Hypersensitivity to any of the ingredients in Prepopik [see Adverse Reactions (6.2)] Risk Summary There are no data with Prepopik use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. In an animal reproduction study, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1
How Supplied Prepopik is supplied in a carton containing 2 packets, each holding 16.1 grams of powder in orange flavor or 16.2 grams of powder in cranberry flavor for oral solution, along with a pre-marked dosing cup. Each packet for both flavors contains 10 mg sodium picosulfate, 3.5 g magnesium oxide and 12 g anhydrous citric acid. The excipients for both flavors include potassium hydrogen carbonate, sodium saccharin, orange or cranberry flavor. The orange flavor contains acacia gum, lactose, ascorbic acid, and butylated hydroxyanisole, and the cranberry flavor contains maltodextrin, glyceryl triacetate (triacetin) and sodium octenyl succinated starch. Storage Store at room temperature between 20 to 25°C (68 to 77°F). Excursions permitted between 15° and 30°C (59° and 86° F) [see USP Controlled room temperature]. Orange flavor: NDC# 55566-9300-2 Kit, 2 packets and cup Cranberry flavor: NDC# 55566-9700-1- Kit, 2 packets and cup
New Drug Application
Ferring Pharmaceuticals Inc. ---------- This Medication Guide has been approved by the U.S. Food and Drug Administration Revised: August 2018 MEDICATION GUIDE PREPOPIK® (prep-ō-pik) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) for oral solution Read and understand this Medication Guide and the Instructions for Use that come with PREPOPIK at least 2 days before your colonoscopy and again before you start taking Prepopik. What is the most important information I should know about Prepopik? Prepopik and other bowel preparations can cause serious side effects, including: Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood. These changes can cause: • abnormal heartbeats that can cause death. • seizures. This can happen even if you have never had a seizure. • kidney problems. Your chance of having fluid loss and changes in blood salts with Prepopik is higher if you: • have heart problems • have kidney problems • take water pills or non-steroidal anti-inflammatory drugs (NSAIDS) Tell your healthcare provider right away if you have any of these symptoms of a loss of too much body fluid (dehydration) while taking Prepopik: • vomiting • urinating less often than normal • dizziness • headache See "What are the possible side effects of Prepopik?" for more information about side effects. What is Prepopik? Prepopik is a prescription medicine used by adults and children 9 years of age and older, to clean the colon before a colonoscopy. Prepopik cleans your colon by causing you to have diarrhea. Cleaning your colon helps your healthcare provider see the inside of your colon more clearly during your colonoscopy. It is not known if Prepopik is safe and effective in children under 9 years of age. Do not take Prepopik if your healthcare provider has told you that you have: • serious kidney problems. • a blockage in your intestine (bowel obstruction). • an opening in the wall of your stomach or intestines (bowel perforation). • a very dilat Read the complete document
PREPOPIK- SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID POWDER, METERED FERRING PHARMACEUTICALS INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE PREPOPIK SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR PREPOPIK . PREPOPIK (SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID) FOR ORAL SOLUTION INITIAL U.S. APPROVAL: 2012 RECENT MAJOR CHANGES Indications and Usage (1) 08/2018 Dosage and Administration (2.3, 2.4) 08/2018 Warnings and Precautions (5.1) 08/2018 INDICATIONS AND USAGE Prepopik is a combination of sodium picosulfate, a stimulant laxative, and magnesium oxide and anhydrous citric acid which form magnesium citrate, an osmotic laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients ages 9 years and older. (1) DOSAGE AND ADMINISTRATION Preparation and Administration Each packet of Prepopik must be dissolved with water prior to ingestion and administered according to the dosing regimen. Direct ingestion of the undissolved powder may increase the risk of nausea, vomiting and dehydration. (2.2, 5.8) Two doses (one packet per dose) of Prepopik are required for a complete preparation for colonoscopy. The preferred method is the "Split-Dose" method. The alternative is the "Day Before" method. (2.1) Additional fluids must be consumed after every dose of Prepopik in both dosing regimens. (2.1, 5.1) Do not take oral medications within 1 hour of start of each dose. (2.1, 7.2) If taking tetracycline or fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, or penicillamine, take these medications at least 2 hours before and not less than 6 hours after administration of Prepopik. (2.1, 7.3) For complete information on preparation before colonoscopy and administration of the dosage regimen, see full prescribing information. (2.1, 2.2, 2.3) Split-Dose Dosage Regimen (Preferred Method) (2.2) First dose: administer during evening before the colonoscopy Read the complete document